Production (Stage)
Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 1.03B | 1.02B | 972.26M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 1.03B | 1.02B | 972.26M | |
| Cost of Revenue | -- | 720.74M | 711.29M | 680.60M | |
| Gross Profit | -- | 308.45M | 303.87M | 291.66M | |
| SG&A Expenses | -- | 257.70M | 254.57M | 243.27M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -237.60K | -1.18M | -116.80K | |
| Total Operating Expenses | -- | 978.20M | 964.68M | 923.76M | |
| Operating Income | -- | 50.99M | 50.48M | 48.50M | |
| Income Before Tax | -- | 24.41M | 24.47M | 24.56M | |
| Income Tax Expenses | -- | 10.93M | 9.75M | 8.72M | |
| Earnings from Continuing Operations | -- | 13.48 | 14.73 | 15.84 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | 13.48M | 14.73M | 15.84M | |
| EBIT | -- | 50.99M | 50.48M | 48.50M | |
| EBITDA | -- | 109.77M | 106.64M | 103.71M | |
| EPS Basic | -- | 0.03 | 0.04 | 0.04 | |
| Normalized Basic EPS | -- | 0.04 | 0.04 | 0.04 | |
| EPS Diluted | -- | 0.03 | 0.04 | 0.04 | |
| Normalized Diluted EPS | -- | 0.04 | 0.04 | 0.04 | |
| Average Basic Shares Outstanding | -- | 1.64B | 1.64B | 1.64B | |
| Average Diluted Shares Outstanding | -- | 1.64B | 1.64B | 1.64B | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |